Time trends in the use of cholesterol-lowering agents in older adults: The cardiovascular health study

Archives of Internal Medicine

Volumn 158, Issue 16, 1998, Pages 1761-1768

  Lemaitre, Rozenn N ^a   Furberg, Curt D ^c   Newman, Anne B ^d,e   Hulley, Stephen B ^f   Gordon, David J ^g   Gottdiener, John S ^h   McDonald Jr , Robert H ^e   Psaty, Bruce M ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID SEQUESTRANT; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PROBUCOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DAILY LIFE ACTIVITY; DIET THERAPY; DISEASE ASSOCIATION; DRUG UTILIZATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0032517073     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.16.1761     Document Type: Article

References (36)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
2. Schucker B, Wittes JT, Santanello NC, et al. Change in cholesterol awareness and action: results from national physician and public surveys. Arch Intern Med. 1991;151:666-673.
3. Nieto FJ, Alonso J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia. Arch Intern Med. 1995;155:677-684.
4. Pieper RM, Arnett DK, McGovern PG, Shahar E, Blackburn H, Luepker RV. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992. Arch Intern Med. 1997;157:2326-2332.
5. Giles WH, Anda RF, Jones DH, Serdula MK, Merritt RK, DeStefano F. Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities. JAMA. 1993;270:1546-1547.
6. LaRosa JC. Cholesterol agonistics. Ann Intern Med. 1996;124:505-508.
7. Grundy SM, Balady GJ, Criqui MH, et al. When to start cholesterol-lowering therapy in patients with coronary heart disease: a statement for healthcare professionals from the American Heart Association Task Force on risk reduction. Circulation. 1997;95:1683-1685.
8. Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley SB. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease: the Heart and Estrogen/Progestin Replacement Study (HERS). JAMA. 1997;277:1281-1286.
9. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age: a report based on the Framingham data. Arch Intern Med. 1993;153:1065-1073.
10. Krumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and CHD mortality and morbidity and all-cause mortality in persons over 70 years. JAMA. 1994;272:1335-1340.
11. Hulley SB, Newman TB. Cholesterol in the elderly: is it important [editorial]? JAMA. 1994;272:1372-1374.
12. Denke MA, Winker MA. Cholesterol and coronary heart disease in older adults: no easy answers [editorial]. JAMA. 1995;274:575-577.
13. Garber AM, Browner WS. Cholesterol screening guidelines: consensus, evidence, and common sense. Circulation. 1997;95:1642-1645.
14. LaRosa JC, Pearson TA. Cholesterol screening guidelines: consensus, evidence, and the departure from common sense. Circulation. 1997;95:1651-1653.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
16. American College of Physicians. Guidelines for using serum cholesterol, high density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 1996;124:515-517.
17. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
18. Manolio TA, Furberg CD, Wahl PW, et al. Eligibility for cholesterol referral in community-dwelling older adults. Ann Intern Med. 1992;116:641-649.
19. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-501.
20. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
21. Breslow NE, Day NE. The Design and Analysis of Cohort Studies: Statistical Methods in Cancer Research. Vol 2. Lyon, France: IARC Scientific Publications; 1987.
22. Wysowski DK, Kennedy DL, Gross TP. Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. JAMA. 1990;263:2185-2188.
23. Use of cholesterol-lowering drugs in the United States, 1992. Stat Bull Metrop Insur Co. 1993;74:10-17.
24. Santanello NC, Barber BL, Applegate WB, et al. Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study. J Am Geriatr Soc. 1997; 45:8-14.
25. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
26. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
27. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
28. Byington RP, Jukema JW, Salonen JT, et al. Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation. 1995;92:2419-2425.
29. Crouse JR III, Byington RP, Hoen HM, Furberg CD. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med. 1997;157:1305-1310.
30. LaRosa JC, Applegate W, Crouse JR III, et al. Cholesterol lowering in the elderly: result of the Cholesterol Reduction in Seniors Program (CRISP) pilot study. Arch Intern Med. 1994;154:529-539.
31. Santiga JT, Rosman HS, Rubenfire M, et al. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. Am J Med. 1994;96:509-515.
32. Landsberg PJ, Mitchel YB, Shapiro D, et al. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Atherosclerosis. 1995;116:153-162.
33. Glasser SP, DiBianco R, Effron BA, et al. The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol >160 mg/ dL. Am J Cardiol. 1996;77:83-85.
34. Weverling-Rijnsburger WE, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RGJ. Total cholesterol and risk of mortality in the oldest old. Lancet. 1997;350:1119-1123.
35. Miettinen TA, Pyorala K, Olsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997;96:4211-4218.
36. Corti M-C, Guralnik JM, Salive ME, et al. Clarifying the direct relationship between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997;126:753-760.